Assignee
XI ANLIBANG PHARMACEUTICAL TECHNOLOGY CO LTD
CN·0 granted patents·2 pending applications·0 citations·filing 2013–2013
Top patents by PatentIndex Score
2 records- 0129US2016038439A1Use of 7-a-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-estra-1,3,5(10)- triene-3,17B-diol and derivatives thereofXI ANLIBANG PHARMACEUTICAL TECHNOLOGY CO LTD·Filed 2013·Application pending·0 cites
- 0229US2016060288A1Ester derivatives of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-estra-1,3,5(10)-triene-3,17beta-diol having anticancer activity and preparation method thereofXI ANLIBANG PHARMACEUTICAL TECHNOLOGY CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XI ANLIBANG PHARMACEUTICAL TECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →